A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
President Donald Trump’s order aimed at limiting services for transgender youth could cut off federal funding but it’s ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.